Albina Nowak

1. WANNER, Christoph, FELDT-RASMUSSEN, Ula, JOVANOVIC, Ana, LINHART, Aleš, YANG, Meng, PONCE, Elvira, BRAND, Eva, GERMAIN, Dominique P., HUGHES, Derralynn A., JEFFERIES, John L., MARTINS, Ana Maria, NOWAK, Albina, VUJKOVAC, Bojan, WEIDEMANN, Frank, WEST, Michael L., ORTIZ, Alberto, et al. Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis. ESC heart failure. jun. 2020, vol. 7, issue 3, p. 825-834, ilustr. ISSN 2055-5822. https://pubmed.ncbi.nlm.nih.gov/32100468/, DOI: 10.1002/ehf2.12647. [COBISS.SI-ID 46714371]

2. HUGHES, Derralynn A., AGUIAR, Patrício, LIDOVE, Olivier, NICHOLLS, Kathleen, NOWAK, Albina, THOMAS, Mark, TORRA, Roser, VUJKOVAC, Bojan, WEST, Michael L., FERIOZZI, Sandro, et al. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet journal of rare diseases. 2022, 17, no. 42, p. 1-15, ilustr. ISSN 1750-1172. https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02181-4#citeas, DOI: 10.1186/s13023-022-02181-4. [COBISS.SI-ID 107205379]

3. LEVSTEK, Tina, BREZNIK, Nika, VUJKOVAC, Bojan, NOWAK, Albina, TREBUŠAK PODKRAJŠEK, Katarina (avtor, korespondenčni avtor). Dynamics of leukocyte telomere length in patients with Fabry disease. Biomedicines. [Online ed.]. 2024, vol. 12, iss. 8, [article no.] 1724, str. 1-9, ilustr. ISSN 2227-9059. https://www.mdpi.com/2227-9059/12/8/1724, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.3390/biomedicines12081724. [COBISS.SI-ID 203575043]
projekt: P1-0170, J3-50113; financer: Slovenian Research Agency

4. WALLACE, Eric L., GOKER-ALPAN, Ozlem, WILCOX, William R., HOLIDA, Myrl, BERNAT, John, LONGO, Nicola, LINHART, Aleš, HUGHES, Derralynn A., HOPKIN, Robert J., TØNDEL, Camilla, LANGEVELD, Mirjam, GIRALDO, Pilar, PISANI, Antonio, GERMAIN, Dominique P., MEHTA, Ankit, DEEGAN, Patrick B., MOLNÁR, Mária Judit, ORTIZ, Damara, JOVANOVIC, Ana, MURIELLO, Michael, BARSHOP, Bruce A., KIMONIS, Virginia, VUJKOVAC, Bojan, NOWAK, Albina, GEBERHIWOT, Tarekegn, KANTOLA, Ikka, KNOLL, Jasmine, WALDEK, Stephen, KHAN, Nedd, KARAA, Amel, BRILL-ALMON, Einat, ALON, Sari, CHERTKOFF, Raul, ROCCO, Rossana, SAKOV, Anat, WARNOCK, David G., et al. Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: : results from the 2-year randomised phase III BALANCE study. Genetics in medicine. 2024, vol. 61, no. 6, p. 520-530, ilustr. ISSN 1530-0366. https://jmg.bmj.com/content/61/6/520, DOI: 10.1136/jmg-2023-109445. [COBISS.SI-ID 224909827]

5. BAHČIČ, Erazem, LEVSTEK, Tina, VUJKOVAC, Bojan, NOWAK, Albina, TREBUŠAK PODKRAJŠEK, Katarina. Identification of potential novel kidney biomarkers and genetic variants associated with Fabry nephropathy. V: NADIŽAR, Nejc (ur.). 19th CFGBC Symposium : book of abstracts : Slovenia, 6th June 2024. Ljubljana: University of Ljubljana, Faculty of Medicine, 2024. Str. 26. http://cfgbc.mf.uni-lj.si/wp-content/uploads/bookofabstracts_2024cfgbcsym19.pdf. [COBISS.SI-ID 205042179]
projekt: P1-0170, J3-50113; financer: Slovenian Research Agency

6. LEVSTEK, Tina, BREZNIK, Nika, VUJKOVAC, Bojan, NOWAK, Albina, TREBUŠAK PODKRAJŠEK, Katarina. Telomere length dynamics is not associated with the disease outcomes in adult fabry patients. V: KRANJC BREZAR, Simona (ur.), ČEMAŽAR, Maja (ur.), MARKELC, Boštjan (ur.). 10th Congress of the Genetic Society of Slovenia & 10th meeting of the Slovenian Society for Human Genetics : book of abstracts : September 25th-28th 2024, Faculty of Tourism Studies - Turistica, Portorož, Slovenia]. 1st ed. Ljubljana: Genetic Society of Slovenia: Slovenian Society of Human Genetics, 2024. Str. 95. ISBN 978-961-93545-9-9. https://genetika24.sgd.si/wp-content/uploads/2024/09/Gen24_Book_of_Abstracts_Web.pdf. [COBISS.SI-ID 211083779]

7. LEVSTEK, Tina, BREZNIK, Nika, VUJKOVAC, Bojan, NOWAK, Albina, TREBUŠAK PODKRAJŠEK, Katarina. Telomere length dynamics is not associated with the disease outcomes in adult Fabry patients. Nephron journals. 2024, vol. 148, suppl. 1, str. [1]. ISSN 2235-3186. https://karger.com/nef/article-abstract/148/Suppl.%201/1/909663/8th-Update-on-Fabry-Disease-Biomarkers-Progression?redirectedFrom=fulltext, DOI: 10.1159/000539834. [COBISS.SI-ID 205314819]

8. LEVSTEK, Tina, VUJKOVAC, Bojan, NOWAK, Albina, OLIVEIRA, João-Paulo, DOSTÁLOVÁ, Gabriela, LINHART, Aleš, ŠAFAŘÍKOVÁ, Marketa, ALTARESCU, Gheona, TREBUŠAK PODKRAJŠEK, Katarina. Exploring genetic factors of Fabry nephropathy progression via whole-exome sequencing : poster presentation at International Conference on Advances in the Treatment of Fabry Disease "New horizon in fabry disease", May 16 -17, 2025, Prague, Czech Republic. https://www.horizons-fabry.com/yia. [COBISS.SI-ID 251674883]
nagrada: Podeljena nagrada

9. LEVSTEK, Tina, VUJKOVAC, Bojan, NOWAK, Albina, OLIVEIRA, João-Paulo, DOSTÁLOVÁ, Gabriela, LINHART, Aleš, ŠAFAŘÍKOVÁ, Marketa, ALTARESCU, Gheona, TREBUŠAK PODKRAJŠEK, Katarina (avtor, korespondenčni avtor). Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing. Molecular genetics and metabolism. 2025, vol. 145, iss. 4, [article no.] 109191, str. 1-5, ilustr. ISSN 1096-7192. https://www.sciencedirect.com/science/article/abs/pii/S1096719225001829?via%3Dihub, DOI: 10.1016/j.ymgme.2025.109191. [COBISS.SI-ID 244325891]
projekt: P1-0170, J3-50113; financer: Slovenian Research Agency
projekt: MH CZ DRO VFN 64165; financer: Czech Ministry of Health

10. LEVSTEK, Tina, VUJKOVAC, Bojan, NOWAK, Albina, OLIVEIRA, João-Paulo, DOSTÁLOVÁ, Gabriela, LINHART, Aleš, ŠAFAŘÍKOVÁ, Marketa, ALTARESCU, Gheona, TREBUŠAK PODKRAJŠEK, Katarina. Uncovering genetic markers for Fabry nephropathy progression through whole-exome sequencing. V: NADIŽAR, Nejc (ur.). 20th CFGBC Symposium : book of abstracts : Slovenia, 11th – 12th June 2025. Electronic version. Ljubljana: University of Ljubljana, Faculty of Medicine, 2025. Str. 61. http://cfgbc.mf.uni-lj.si/wp-content/uploads/2025cfgbcsym20_bookofabstracts.pdf. [COBISS.SI-ID 240270595]
projekt: P1-0170 ; J3-50113; financer: Slovenian Research and Innovation Agency, as well as Takeda Pharmaceuticals d.o.o.